Supply Chain/Technology

Latest Issue of OR Manager
May 2025
Home Supply Chain/Technology

Why active implants demand proactive management

What happens when a surgeon uses the monopolar instrument set on 30-W coagulation mode to create an upper midline incision in a patient with a pacemaker? Pacemaker function is interrupted, causing a heart block that results in hemodynamic instability—or at least, this is what could happen without taking the necessary…

Read More

By: Mary A. Marvin, APRN-BC and Jill Teubel, MSN, RN
January 1, 2025
Share

Orthopedic research showcases stem cells’ surgical promise

Stem cell therapy is poised to revolutionize regenerative medicine. As these therapies advance, they may alter or even replace certain invasive surgical procedures. Already undergoing advanced clinical trials, orthopedic applications are likely candidates for attracting the earliest adopters. Results so far indicate significant potential for providing alternatives to implants, grafts,…

Read More

By: Stephanie Reda
January 1, 2025
Share

Implications of 2024 surgical care trends for the year ahead

Perioperative leaders are entering a time of uncertainty after 2024 proved to be transformative for inpatient and outpatient surgical care. Last year saw important updates from The Joint Commission and the Centers for Medicare & Medicaid Services (CMS) that emphasized improvements alongside ongoing challenges in safety, workforce shortages, reimbursement, and…

Read More

By: Tarsilla Moura
January 1, 2025
Share

FDA designates Class 1 recalls for balloon catheters, radiographic markers

Editor's Note Balloon catheters for atrial fibrillation patients and implantable radiographic markers were the subjects of separate US Food and Drug Administration (FDA) Class 1 recalls—the most severe category indicating risk of serious injury or death—announced on December 18. The first recall involves Boston Scientific’s POLARx Cryoablation devices. Higher-than-anticipated reports…

Read More

By: Matt Danford
December 19, 2024
Share

Sponsored Message

Medtronic, Zimmer Biomet challenge Intuitive Surgical’s robotic surgery dominance

Editor's Note Robotic-assisted surgical procedures are no longer futuristic—they are becoming a mainstay in modern ORs. While Intuitive Surgical’s da Vinci system has led the market since 2001, competitors Medtronic and Zimmer Biomet are building innovative portfolios to challenge its dominance, MarketBeat December 12 reports. Medtronic’s Hugo Robotic Assisted Surgery…

Read More

By: Tarsilla Moura
December 18, 2024
Share

Surgeons emphasize bariatric surgery benefits amid rising GLP-1 drug popularity

Editor's Note Bariatric surgery programs nationwide have reported a 20-25% decline in surgical volumes over the past year amid the rising use of glucagon-like peptide-1 (GLP-1) medications for obesity, OR Management News reported Dec 2. Although the connection between the decline and the popularity of the drugs cannot be definitively…

Read More

By: Matt Danford
December 18, 2024
Share

Sponsored Message

Costs drop, access expands for GLP-1 weight loss drugs

Editor's Note Access to GLP-1 medications is improving as manufacturers, insurers, and policymakers address high demand, costs, and coverage challenges, Becker’s Hospital Review reported December 13. As detailed in the article, Eli Lilly’s partnership with telehealth company Ro now allows patients to obtain Zepbound prescriptions online and receive shipments directly…

Read More

By: Matt Danford
December 13, 2024
Share

Q&A: Perioperative immunotherapy advances for early-stage NSCLC

Editor's Note Perioperative immunotherapy is reshaping treatment strategies for early-stage non-small cell lung cancer (NSCLC) without actionable mutations, according to Dr. Roy S. Herbst of Yale Cancer Center. In a recent interview with OncLive, the oncology expert highlighted the promise of neoadjuvant and adjuvant therapies to improve outcomes for these…

Read More

By: Matt Danford
December 13, 2024
Share

ASA recommendations target postoperative delirium in older patients

Editor's Note Efforts to reduce the risk of postoperative delirium in older patients should focus on preoperative evaluation, anesthesia choices, and medication management, according to the American Society of Anesthesiologists (ASA). Designed specifically for treating adults aged 65 and older undergoing inpatient surgery, these new, evidence-based recommendations are presented in…

Read More

By: Matt Danford
December 12, 2024
Share

Infusion pump problems prompt early FDA safety warning

Editor's Note Risk of delayed therapy and death related to Ivenix large-volume infusion pumps is prompting supplier Fresenius Kabi USA to pull a subset of the devices from the market, according to an early alert from The US Food and Drug Administration (FDA). Issued December 11, the early alert is…

Read More

By: Matt Danford
December 12, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat